Previous Close | 0.0092 |
Open | 0.0070 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0092 - 0.0092 |
52 Week Range | 0.0021 - 0.0210 |
Volume | |
Avg. Volume | 20,045 |
Market Cap | 3.387M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2700 |
Earnings Date | Apr 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Company Financials for Full-Year 2023 will be filed after market close on April 29, 2024TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024.
Chief Legal Officer and Corporate Secretary to step down effective December 18, 2023 TORONTO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, today announced that Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, will step down to pursue other career opportunities, effective December 18, 2023. Mr. Doré joined Entourage Health
Entourage sees the benefits of transitioning from cultivation and reports over $10 million to date in annualized cost savings.Gross Profit Before Fair Value Changes has surged to $2.4 million, indicating a substantial margin of 27% and a 149% year-over-year increase.Management is to host a conference call on November 28, 2023, at 10 a.m. Eastern Time. TORONTO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian